Global Tamoxifen Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025

  • ID: 4394888
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Allergen plc
  • Apotex, Inc
  • Astra Zeneca plc
  • MORE

The tamoxifen market was valued at USD 676.6 Mn in 2017, and is expected to reach USD 683.6 Mn by 2025, expanding at a CAGR of 0.07% from 2017 - 2025.

Market Insights

Tamoxifen is the oldest and among the most prescribed selective estrogen receptor modulator for breast cancer treatment and management. Tamoxifen is approved for early stage, hormone receptor positive breast cancer in men and women, after surgery or chemotherapy to reduce recurrence risk, and for management of advanced stage or metastatic hormone-receptor positive breast cancer. Women at high risk of developing breast cancer also use Tamoxifen. Tamoxifen is at the maturity stage of product life cycle and is anticipated to experience decline in market growth in the light of introduction of advanced breast cancer management drugs.

This report analyzes the geographical distribution of tamoxifen market in North America, Europe, Asia-Pacific and Rest of the World markets. Currently, North America is the largest market for tamoxifen drugs and it is anticipated that the lead of this region will continue through 2022. Large pool of breast cancer patients, high awareness for breast cancer screening and prevention, well-structured reimbursement scenario and large pool of breast cancer patients. Asia-Pacific and Rest of the World markets will experience the fastest CAGR during 2016-2022. Improving awareness in Middle East and Africa, high incidence of late stage breast cancer in these regions and rapid development of healthcare infrastructure are the prime drivers of Rest of the World market.

Proven long-term efficiency of hormone therapy for management and control of breast cancer across various stages of treatment, in geriatric patients that cannot opt for surgery, and late-stage and recurrent breast cancer, and widespread use of tamoxifen as adjuvant therapy are the prime factors driving the demand for tamoxifen. Growth of tamoxifen-resistant cancer and growing awareness about the drug inducing endometrial cancer may restrain the market growth. Growing application of tamoxifen in treatment of conditions such as McCune-Albright syndrome, infertility, gynecomastia, bipolar disorder, angiogenesis and Riedel’s thyroiditis, and its use in research studies involving gene expression serve as future avenues for the growth of this market.

The global tamoxifen market is moderately competitive with AstraZaneca, Teva Pharmaceutical Industries, Allergan, Mylan, Apotex and Midatech the known players. Anticipated merger of Teva with Allergan is expected to bring a shift in market competition.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergen plc
  • Apotex, Inc
  • Astra Zeneca plc
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary

Chapter 3 Tamoxifen: Market Dynamics and Outlook
3.1 Introduction
3.2 Breast Cancer: Key Statistics
3.3 Major Events Assessment
3.4 Market Dynamics
3.4.1 Drivers
3.4.1.1 Advantages of Hormone Therapy Across Different Stages of Treatment
3.4.1.2 Widespread use as Adjuvant and Neo-Adjuvant Therapy
3.4.2 Challenges
3.4.2.1 Growth in Tamoxifen-Resistant Breast Cancer
3.4.3 Opportunities
3.4.3.1 Alternative uses of Tamoxifen
3.5 Attractive Investment Proposition
3.6 Market Positioning of Key Manufacturers

Chapter 4 Global Tamoxifen Market, Pipeline Analysis
4.1 Preface
4.2 Phase III
4.3 Phase II
4.4 Phase I

Chapter 5 Global Tamoxifen Market, by Geography
5.1 Introduction
5.2 North America
5.2.1 U.S.
5.2.2 Canada
5.3 Europe
5.3.1 United Kingdom
5.3.2 Germany
5.3.3 Rest of Europe
5.4 Asia-Pacific
5.4.1 China
5.4.2 Japan
5.4.3 Rest of Asia-Pacific
5.5 Rest of the World

Chapter 6 Company Profiles
6.1 Astra Zeneca plc
6.1.1 Astra Zeneca plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.2 Teva Pharmaceutical Industries Ltd.
6.2.1 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.3 Allergen plc
6.3.1 Allergen plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.4 Mylan Pharmaceuticals, Inc.
6.4.1 Mylan Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.5 Apotex, Inc
6.5.1 Apotex, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)

List of Figures
Fig. 1 Global Tamoxifen Market: Research Methodology
Fig. 2 Global Tamoxifen Market, by Geography, 2015 (US$ Mn)
Fig. 3 Attractive Investment Proposition: Global Tamoxifen Market, by Geography, 2015
Fig. 4 Market Positioning of Key Manufacturers in Tamoxifen Market, 2015 (Value %)
Fig. 5 U.S. Tamoxifen Market, 2013 - 2022 (US$ Mn)
Fig. 6 Canada Tamoxifen Market, 2013 - 2022 (US$ Mn)
Fig. 7 European Age-Standardized Mortality Rates per 100,000 Population, Females, U.K.
Fig. 8 United Kingdom Tamoxifen Market, 2013 - 2022, (US$ Mn)
Fig. 9 Germany Tamoxifen Market, 2013 - 2022, (US$ Mn)
Fig. 10 Rest of Europe Tamoxifen Market, 2013 - 2022, (US$ Mn)
Fig. 11 China Tamoxifen Market Revenue, 2015 - 2022 (US$ Mn)
Fig. 12 Japan Tamoxifen Market, 2013- 2022 (US$ Mn)
Fig. 13 Rest of Asia-Pacific Tamoxifen Market, 2013 - 2022 (US$ Mn)

List of Tables
Table 1 Global Tamoxifen Market Revenue, 2017 Vs 2025 (US$ Mn)
Table 2 National Statistics: Breast Cancer Incidence Rate for Key Countries, 2012
Table 3 North America Tamoxifen Market, by Country, 2015-2025 (US$ Mn)
Table 4 Estimated New Female Breast Cancer Cases and Deaths by Age, U.S., 2013
Table 5 Canada Breast Cancer Statistics, 2015
Table 6 Europe Tamoxifen Market, 2015-2025, (US$ Mn)
Table 7 Breast Cancer Incidence Rate and Mortality Rate in Germany, 2012
Table 8 Breast Cancer Incidence Rate in Rest of European Countries, 2012
Table 9 Breast Cancer Survivors Post Diagnosis in Rest of European Countries, 2012
Table 10 Asia-Pacific Tamoxifen Market, 2015-2025 (US$ Mn)
Table 11 Rest of the World Tamoxifen Market, by Region, 2015-2025
Table 12 Astra Zeneca plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 13 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 14 Allergen plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 15 Mylan Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 16 Apotex, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Astra Zeneca plc
  • Teva Pharmaceutical Industries Ltd.
  • Allergen plc
  • Mylan Pharmaceuticals, Inc.
  • Apotex, Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll